-
Symbol
-
PRLD on Nasdaq
-
Investment type
-
Equity / Common Stock, par value $0.0001 per share
-
Latest Disclosed Shares Owned
-
4,372,124 shares
-
Security Ownership %
-
9.9%
INCYTE CORP ownership in Prelude Therapeutics Inc Common Stock, par value $0.0001 per share (PRLD)
07 Nov 2025 - INCYTE CORP has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 4,372,124 shares of Prelude Therapeutics Inc Common Stock, par value $0.0001 per share (PRLD).
This represents 9.9% ownership of the company.
This is the first filing by INCYTE CORP disclosing ownership of Prelude Therapeutics Inc Common Stock, par value $0.0001 per share (PRLD).